Observational look at how Kremezin works in adults with advanced chronic kidney disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, prospective observational study in adults with advanced chronic kidney disease who, as part of standard care, are prescribed Kremezin immediate-release tablets or fine granules. Data are collected during routine visits at baseline, week 24, and week 48 to assess kidney function (creatinine and eGFR), overall effectiveness, safety, and treatment satisfaction. No study-imposed interventions are required beyond standard clinical practice, and treatment decisions are made before consent. The study aims to reflect real-world use and outcomes of Kremezin in this patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 19 years or older diagnosed with advanced chronic renal failure.
* Individuals who voluntarily decide to participate and provide written informed consent.

Exclusion Criteria:

* Individuals for whom Kremezin immediate-release tablets or Kremezin fine granules are contraindicated according to the product labeling.
* Individuals with AST or ALT levels at least three times the upper limit of normal.
* Individuals with chronic alcoholism.
* Individuals with an active or progressive infection.
* Pregnant or breastfeeding individuals.
* Individuals with a history of dialysis.

Where it's running

• HK inno.N
  Seoul, South Korea Recruiting

Study contacts

• Study coordinator: Yongan Jeong
• Email: yongan.jeong@inno-n.com
• Phone: +82-31-5176-4673

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China

  This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.

  Recruiting Phase 4 Novo Nordisk A/S · Fuyang, Anhui and 25 other locations · NCT07900438

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• Arterial stiffness in children and young people with CKD and hypertension

  This study will test whether arterial stiffness is higher in children and young people with chronic kidney disease and high blood pressure compared with their peers, using a one-time assessment and follow-up for those with high BP.

  Recruiting King's College London · London, Greater London · NCT07768865

• Self-Management Data and Disease Progression in CKD

  This study tests whether patient-recorded self-management data collected via a mobile app can be linked to CKD progression in adults seen at a university hospital.

  Recruiting Chungnam National University Hospital · Daejeon, DJ · NCT07754097

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.